Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR5 (clone HTRA-8P). We employs the Lentivirus (EF1α-GFP-c-Fos-XbaI) vector components and the SynExpress system of the Introns Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
DR5
Clone
HTRA-8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
Lentivirus
Transformation Accuracy
0.86
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.